AVDL
Avadel Pharmaceuticals
AVDL
AVDL
101 hedge funds and large institutions have $856M invested in Avadel Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 34 increasing their positions, 24 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.7% more ownership
Funds ownership: 78.39% → 84.1% (+5.7%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
7% less call options, than puts
Call options by funds: $21.6M | Put options by funds: $23.1M
Holders
101
Holding in Top 10
7
Calls
$21.6M
Puts
$23.1M
Top Buyers
| 1 | +$44.2M | |
| 2 | +$17.6M | |
| 3 | +$11.5M | |
| 4 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$8.24M |
| 5 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$8.24M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$10.7M | |
| 3 | -$7.28M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$5.4M |
| 5 |
TLP
Tri Locum Partners
New York
|
-$4.74M |